Diagnosing patients with hereditary paraganglial tumours

The Lancet Oncology

Volumn 10, Issue 8, 2009, Pages 741-

  Erlic, Zoran ^a   Neumann, Hartmut PH ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME SUBUNIT; FAMILIAL CANCER; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MEDIASTINUM TUMOR; PARAGANGLIOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; TISSUE FIXATION; TUMOR DIAGNOSIS; WATCHFUL WAITING;

ADRENAL GLAND NEOPLASMS; HUMANS; MUTATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE;

EID: 67651148117     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70204-9     Document Type: Letter

References (5)

1. Neumann H.P., Bausch B., McWhinney S.R., et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346 (2002) 1459-1466
2. Neumann H.P., Erlic Z., Boedeker C.C., et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 69 (2009) 3650-3656
3. van Nederveen F.H., Gaal J., Favier J., et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10 (2009) 764-771
4. Anon. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21 (2003) 2397-2406
5. Erlic Z., and Neumann H.P. Clinical question: When should genetic testing be obtained in a patient with pheochromocytoma or paraganglioma?. Clin Endocrinol (Oxf) 70 (2009) 354-357